Pharma News

People who have had a heart attack may be slightly less likely than people in the general population to develop Parkinsons disease later in life, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

Using powerful tools and techniques developed in the field of structural biology, researchers at the University of Washington and Scripps Research have discovered new details about the human immunodeficiency virus, HIV. The findings bring into focus the basic architecture of the virus just above and below its surface and may help in the design and development of a vaccine that can protect against AIDS.

Cold weather can be hard on your skin. When your skin becomes dry, as often happens in the winter, it can easily crack and bleed. When caring for a cut or other wound, it might seem logical to apply an antibiotic cream or ointment from the store to fight off germs and prevent infection. However, these antibiotic creams and ointments can irritate your skin even more and cause a painful and/or itchy rash, called contact dermatitis.

Revive Therapeutics Ltd a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that the U.S. Food and Drug Administratio has granted Orphan Drug Designation for Bucillamine for the prevention of ischemia–reperfusion injury during liver transplantation.

Researchers in Lund have discovered an antitoxin mechanism that seems to be able to neutralise hundreds of different toxins and may protect bacteria against virus attacks. The mechanism has been named Panacea, after the Greek goddess of medicine whose name has become synonymous with universal cure. The understanding of bacterial toxin and antitoxin mechanisms will be crucial for the future success of so-called phage therapy for the treatment of antibiotic resistance infections, the researchers say. The study has been published in PNAS.

A Caltech-led team of researchers has discovered that a small-molecule metabolite, produced by bacteria that reside in the mouse gut, can travel to the brain and alter the function of brain cells, leading to increased anxiety in mice. The work helps uncover a molecular explanation for recent observations that gut microbiome changes are associated with complex emotional behaviors.

Based on the intricacies of origami and inspired by the movements of nature’s leeches his research is advancing how robots could carry out basic health care tasks in certain conditions, including in remote regions, or where minimal personal contact is needed, such as during pandemics. The research is published in the journal npj Flexible Electronics from Nature Publishing Group.

Decreased serum vitamin B12 levels are independently associated with the development of narcolepsy, a sleep disorder, said recent research. The novel study illustrates the complex relationship between vitamin B12 and narcolepsy.

Biopharmaceutical R&D continued at a record breaking pace in 2021 despite the COVID-19 pandemic, according to a new report, Global Trends in R&D Overview Through 2021, by the IQVIA Institute for Human Data Science. The data show 5,500 new planned clinical trial starts occurred last year, a 14 percent increase over 2020.